121 related articles for article (PubMed ID: 1352471)
1. Backbone modifications in somatostatin analogues: relation between conformation and activity.
Van Binst G; Tourwé D
Pept Res; 1992; 5(1):8-13. PubMed ID: 1352471
[TBL] [Abstract][Full Text] [Related]
2. Conformational mobility in cyclic oligopeptides.
Kopple KD; Bean JW; Bhandary KK; Briand J; D'Ambrosio CA; Peishoff CE
Biopolymers; 1993 Jul; 33(7):1093-9. PubMed ID: 8102073
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
[TBL] [Abstract][Full Text] [Related]
4. Peptide conformation. 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin.
Kessler H; Klein M; Wagner K
Int J Pept Protein Res; 1988 May; 31(5):481-98. PubMed ID: 2900820
[TBL] [Abstract][Full Text] [Related]
5. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
[TBL] [Abstract][Full Text] [Related]
6. Solution structures of cyclic and dicyclic analogues of growth hormone releasing factor as determined by two-dimensional NMR and CD spectroscopies and constrained molecular dynamics.
Fry DC; Madison VS; Greeley DN; Felix AM; Heimer EP; Frohman L; Campbell RM; Mowles TF; Toome V; Wegrzynski BB
Biopolymers; 1992 Jun; 32(6):649-66. PubMed ID: 1643268
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
9. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.
D'Addona D; Carotenuto A; Novellino E; Piccand V; Reubi JC; Di Cianni A; Gori F; Papini AM; Ginanneschi M
J Med Chem; 2008 Feb; 51(3):512-20. PubMed ID: 18210999
[TBL] [Abstract][Full Text] [Related]
10. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
[TBL] [Abstract][Full Text] [Related]
12. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
14. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
Yamazaki T; Nunami K; Goodman M
Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
[TBL] [Abstract][Full Text] [Related]
15. Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity.
Pakkala M; Jylhäsalmi A; Wu P; Leinonen J; Stenman UH; Santa H; Vepsäläinen J; Peräkylä M; Närvänen A
J Pept Sci; 2004 Jul; 10(7):439-47. PubMed ID: 15298179
[TBL] [Abstract][Full Text] [Related]
16. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
18. Common structural features for cytoprotection activities of somatostatin, antamanide and related peptides.
Kessler H; Gehrke M; Haupt A; Klein M; Müller A; Wagner K
Klin Wochenschr; 1986; 64 Suppl 7():74-8. PubMed ID: 2882054
[No Abstract] [Full Text] [Related]
19. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
[TBL] [Abstract][Full Text] [Related]
20. Conformational and topographical considerations in the design of biologically active peptides.
Hruby VJ
Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
